Common Contracts
11 similar null contracts by Lion Group Holding LTD, Safe-T Group Ltd., Rosetta Genomics Ltd., others
CONVERTIBLE DEBENTURE DUE JANUARY 23, 2027Lion Group Holding LTD • January 23rd, 2024 • Security brokers, dealers & flotation companies • New York
THIS CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Convertible Debentures of Lion Group Holding Ltd., a Cayman Islands exempted company (the “Company”), having its principal place of business at 3 Phillip Street, #15-04 Royal Group Building, Singapore 048693, designated as its Convertible Debenture due January 23, 2027(this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
CONVERTIBLE DEBENTURE DUE September 5, 2026Lion Group Holding LTD • September 5th, 2023 • Security brokers, dealers & flotation companies • New York
THIS CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Convertible Debentures of Lion Group Holding Ltd., a Cayman Islands exempted company (the “Company”), having its principal place of business at 3 Phillip Street, #15-04 Royal Group Building, Singapore 048693, designated as its Convertible Debenture due September 5, 2026 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE DUE __________ 20251Edoc Acquisition Corp. • August 24th, 2023 • Fats & oils • New York
THIS 10% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Original Issue Discount Secured Convertible Debentures of Australian Oilseeds Holdings Limited, an exempted company incorporated under the laws of Cayman Islands (together with its successors and assigns, the “Company”), whose registered office in the Cayman Islands is c/o Stuarts Corporate Services Ltd., 69 Dr Roy’s Drive, P.O. Box 2510, Grand Cayman KY1-1104, Cayman Islands, designated as its 10% Original Issue Discount Secured Convertible Debenture due _____________ 2025 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
CONVERTIBLE DEBENTURE DUE August 9, 2025Lion Group Holding LTD • August 10th, 2022 • Security brokers, dealers & flotation companies • New York
THIS CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Convertible Debentures of Lion Group Holding Ltd., a Cayman Islands exempted company (the “Company”), having its principal place of business at 3 Phillip Street, #15-04 Royal Group Building, Singapore 048693, designated as its Convertible Debenture due August 9, 2025 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
8% SENIOR SECURED CONVERTIBLE DEBENTURE DUE , 20232Ucommune International LTD • January 28th, 2022 • Services-business services, nec • New York
THIS 8% SENIOR SECURED CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 8% Senior Secured Convertible Debentures of Ucommune International Ltd, a Cayman Islands exempted company (the “Company”), having its principal place of business at Floor 8, Tower D, No. 2 Guang Hua Road, Chaoyang District, Beijing, People’s Republic of China, 100026, designated as its 8% Senior Secured Convertible Debenture due _______________, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
9% SENIOR SECURED CONVERTIBLE DEBENTURE DUE JUNE 14, 2023Lion Group Holding LTD • December 16th, 2020 • Security brokers, dealers & flotation companies • New York
THIS 9% SENIOR SECURED CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 9% Senior Secured Convertible Debentures of Lion Group Holding Ltd., a Cayman Islands exempted company (the “Company”), having its principal place of business at Unit A-C, 33/F, Tower A, Billion Center, 1 Wang Kwong Road, Kowloon Bay, Hong Kong, designated as its 9% Senior Secured Convertible Debenture due June 14, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
8% CONVERTIBLE DEBENTURE DUE June 26, 2021Safe-T Group Ltd. • December 30th, 2019 • Services-prepackaged software • New York
THIS 8% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 8% Convertible Debentures of Safe-T Group Ltd., an Israeli corporation (the “Company”), having its principal place of business at 8 Aba Even St., Herzliya L3 4672526, designated as its 8% Convertible Debenture due June 26, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
8% CONVERTIBLE DEBENTURE DUE May 8, 2021Safe-T Group Ltd. • November 12th, 2019 • Services-prepackaged software • New York
THIS 8% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 8% Convertible Debentures of Safe-T Group Ltd., an Israeli corporation (the “Company”), having its principal place of business at 8 Aba Even St., Herzliya L3 4672526, designated as its 8% Convertible Debenture due May 8, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
8% CONVERTIBLE DEBENTURE DUE March 4, 2021Safe-T Group Ltd. • August 30th, 2019 • Services-prepackaged software • New York
THIS 8% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 8% Convertible Debentures of Safe-T Group Ltd., an Israeli corporation (the “Company”), having its principal place of business at 8 Aba Even St., Herzliya L3 4672526, designated as its 8% Convertible Debenture due March 4, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
CONVERTIBLE DEBENTURE DUE OCTOBER 2, 2047Rosetta Genomics Ltd. • October 11th, 2017 • Pharmaceutical preparations • New York
THIS CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Convertible Debentures of Rosetta Genomics Ltd., an Israeli corporation (the “Company”), having its principal place of business at 10 Plaut Street, Science Park, Rehovot 76706, Israel, designated as its Convertible Debenture due October 2, 2047 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
CONVERTIBLE DEBENTURE DUE November 29, 2046Rosetta Genomics Ltd. • November 25th, 2016 • Pharmaceutical preparations • New York
THIS CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Convertible Debentures of Rosetta Genomics Ltd., an Israeli corporation, (the “Company”), having its principal place of business at 10 Plaut Street, Science Park, Rehovot 76706, Israel, designated as its Convertible Debenture due November 29, 2046 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
